Q-Line Biotech

What Q-Line Biotech does

Q-Line Biotech Limited is an Indian in-vitro diagnostics (IVD) manufacturer and supplier operating since 2013 (incorporated in 2010 as POCT Services Private Limited). The company designs, manufactures, and distributes a comprehensive IVD portfolio spanning seven categories: clinical chemistry (semi-automated and fully-automated biochemistry analyzers such as the Astira C-MS, Selectra Pro M Lite, and Innolab series), haematology (3-part and 5-part cell counters including the proprietary Q-Count line and distributed Boule Medonic M32/M51, plus the HPLC-based Q-A1cH10 hemoglobin analyzer), molecular diagnostics (PCR instruments and the Q-Xtra Plus 32W extraction system), point-of-care testing, rapid tests (HIV, hepatitis, dengue, malaria, syphilis, pregnancy), ELISA (Q-Lisa kits, readers, washers), and special diagnostics. Manufacturing occurs at facilities in Lucknow (Kanpur Road, Transport Nagar) and Delhi (Bawana Industrial Area), with corporate headquarters at Naraina Industrial Area, New Delhi. The company holds ISO 13485:2016, ISO 9001:2015, CE marking, and CDSCO certifications, and its Selectra Pro systems are US-FDA registered.

Q-Line operates a razor-and-blade business model combining one-time analyzer sales with recurring reagent and consumable revenue, plus after-sales service (AMC contracts). Reagent sales surged 70% in FY26, driving EBITDA margin expansion to 28.7%. The go-to-market is primarily B2B through a pan-India distributor network covering Tier 1-3 cities, supplemented by direct enterprise sales to hospitals, diagnostic laboratories, blood banks, and public health programs. International distribution partners serve 65+ countries, and a new CDMO service line targets contract manufacturing for global IVD brands. The company completed its IPO on NSE SME Emerge in May 2026, raising approximately ₹214.48 crore at a 32% listing premium, with anchor investments from Abakkus Mutual Fund, Carnelian Capital, 360 ONE, HDFC Bank, and Bharat Venture Opportunities Fund. FY26 revenue reached ₹34,174 lakh with PAT of ₹5,572 lakh (+190% YoY), and management has guided to 30-35% revenue growth for FY27.

Name

Q-Line Biotech

Legal name

Q-Line Biotech Limited

Website

https://qlinebiotech.com

Company type

Public

Founded year

2013

Operating status

Ipo

Headcount range

11–50 employees

Short description

Q-Line Biotech is an Indian in-vitro diagnostics manufacturer founded in 2013, producing clinical chemistry analyzers, hematology instruments, rapid tests, ELISA kits, and molecular diagnostics for hospitals, laboratories, blood banks, and public health programs across India and 65+ countries.

Ownership category

akta.pro rank

Product category

In-Vitro Diagnostics (IVD) Manufacturing

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516), Surgical and Medical Instrument Manufacturing (339112)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)

akta.pro primary industry

IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)

akta.pro secondary industries

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI), Quality Control, Calibrators, Standards & Proficiency Testing (IVD Consumables) (HLAHAAAL), Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL)

Keywords

• In-vitro diagnostics products
• Clinical chemistry analyzers
• Haematology analyzers
• Rapid diagnostic test kits
• Diagnostic reagents consumables

Headquarters

HQ city

New Delhi

HQ country

India

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Diagnostic Reagents and Consumables: Recurring revenue from manufactured reagents including clinical chemistry reagents, haematology reagents, rapid test kits, and molecular diagnostic kits. 70% surge in manufactured reagent sales contributed to margin expansion in FY26.
2. IVD Equipment and Analyzers: One-time sales of diagnostic instruments including biochemistry analyzers, haematology analyzers, ELISA readers/washers, PCR instruments, and point-of-care devices.
3. Service and Support: After-sales service and support including AMC (Annual Maintenance Contracts), technical service teams, and installation support for laboratory equipment.
4. CDMO Services: Contract Development and Manufacturing Operations expanding internationally for diagnostic products.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels6 records

Core offering

Q-Line Biotech manufactures and supplies a comprehensive in-vitro diagnostics (IVD) portfolio including clinical chemistry analyzers, haematology analyzers, ELISA readers/washers and kits, PCR instruments and molecular extraction systems, point-of-care testing devices, and a broad range of rapid immunochromatographic test kits, all supported by the company's own reagent and consumable manufacturing. The instruments are sold to hospitals, diagnostic laboratories, blood banks, and public health programs, while reagents and consumables generate recurring revenue from the installed base across India and 65+ export countries.

Product overview

Q-Line Biotech is an Indian in-vitro diagnostics (IVD) company operating since 2013 that manufactures and supplies a comprehensive portfolio of diagnostic products across seven categories: Clinical Chemistry (including biochemistry analyzers such as Microlab 300, Astira C-MS, Selectra Pro S Lite, Selectra Pro M Lite, Innolab 200, Innolab 200plus, and ASTIRA CX400), Haematology (including Medonic M32, Medonic M51, Q-Count 3, Q-Count 5, and Q-A1cH10 Hemoglobin Analyzer), POC Testing, Molecular Diagnostics (including PCR instruments and extraction systems), Rapid Tests (Q-Line Rapid Exclusive brand including HIV Ag-Ab 4th Gen, HIV/Syphilis Duo, Dengue tests, Malaria tests, HCV, HBsAg, and pregnancy tests), ELISA (including Q-Lisa ELISA Kits and readers/washers), and Special Diagnostics (including osmometer and sweat induction equipment). The company operates a recurring revenue model through reagent and consumable supplies alongside instrument sales.

Differentiator

Problem solved

Functional benefit

Brands

• Q-Line Rapid Exclusive: Brand for rapid test kits including HIV, Malaria, Dengue, Hepatitis, and other infectious disease tests
• Q-Lisa ELISA Kits
• Q-Count
• Q-A1cH10 Hemoglobin Analyzer

Products and services

• Microlab 300 Semi-Automated Biochemistry Analyzer Semi-automated clinical chemistry analyzer with 60 programmable tests, a broad test menu, and cost-effective operation, targeted at smaller or satellite laboratory locations in India.
• Astira C-MS Automated Clinical Chemistry Analyzer Benchtop discrete random-access clinical chemistry analyzer with constant throughput of 240 tests/hr, a prism grating system with 12 wavelengths, 40+ sample positions, 40+ reagent positions, and integrated collision and level sensors for hospital and reference laboratories.
• Innolab 200 Semi-Automatic Biochemistry Analyzer Semi-automatic clinical chemistry analyzer with quartz flow cell, large touch screen, 300 programmable tests, and a comprehensive biochemistry menu validated with Q-Line reagents for routine hospital and laboratory use.
• Selectra Pro M Lite Fully-Automated Clinical Chemistry Analyzer US-FDA registered fully-automated clinical chemistry analyzer with throughput up to 180 photometric tests/hour, very low water requirement (<1 liter/hr), best-in-class operator interface, and automated reagent management for mid- to high-volume laboratories.
• Selectra Pro S Lite Fully-Automated Clinical Chemistry Analyzer US-FDA registered fully-automated clinical chemistry analyzer with throughput up to 140 photometric tests/hour, designed for smaller or satellite laboratory locations.
• ASTIRA CX400 Fully-Automated Clinical Chemistry Analyzer Fully automated clinical chemistry analyzer designed for high-volume laboratory testing workloads.
• Innolab 200plus Semi-Auto Clinical Chemistry Analyzer Semi-auto clinical chemistry analyzer positioned as an upgrade to the Innolab 200, targeted at smaller laboratories seeking innovation and reliable test menus.
• Medonic M32 3-Part Cell Counter Compact 3-part cell counter hematology analyzer from Boule, Sweden, distributed by Q-Line Biotech in India with highly accurate results and low maintenance needs for routine CBC testing.
• Medonic M51 5-Part Cell Counter Entry-level 5-part cell counter hematology analyzer from Boule, Sweden, with throughput of 60 samples/hr in CBC mode and 45/hr in CBC+diff mode, 29 parameters, and a closed 3-reagent system, distributed by Q-Line Biotech for clinical laboratories.
• Q-Count 3 Hematology Analyzer Fully automated 3-part hematology analyzer using electrical impedance measurement and cyanide-free HGB measurement technology, with capacity for over 100,000 stored samples, 24 reporting parameters, and low reagent consumption (only two reagents required).
• Q-Count 5 Hematology Analyzer 5-part hematology analyzer based on laser scatter flow cytometry technology for WBC and WBC differential measurement, with built-in thermal printer and touch functionality for clinical laboratories.
• Q-A1cH10 Hemoglobin Analyzer Fully automated HbA1c analyzer using High Pressure Liquid Chromatography (HPLC) technology, providing HbA1c results in 130 seconds with Hb variant detection, automated 10-position primary tube sampling with cap piercing, for diabetic monitoring in clinical settings.
• HIV Ag-Ab 4th Generation Rapid Test Card Lateral flow rapid test card for simultaneous visual detection of HIV 1/2 antibodies and HIV-1 p24 antigen in human whole blood, serum, or plasma, sold under the Q-Line Rapid Exclusive brand for hospitals, blood banks, and public health screening.
• HIV/Syphilis Duo Rapid Test Lateral flow test for rapid, simultaneous and separate detection of HIV 1/2 and Syphilis antibodies on a single test card, with results in 20 minutes and room-temperature storage for blood bank and antenatal screening.
• Rapid HBsAg Test Q-Line Rapid lateral flow test for qualitative detection of Hepatitis B surface antigen (HBsAg) in serum or plasma, used in blood donor screening and clinical infectious disease workups.
• HCV Antibody 3rd Generation Rapid Test Q-Line Rapid 3rd-generation lateral flow test for detection of Hepatitis C virus antibodies in whole blood, serum, or plasma for point-of-care screening at blood banks and physician offices.
• Dengue Combo Rapid Test Q-Line Rapid combo test kit detecting both NS1 antigen and differential IgM/IgG antibodies to dengue virus in human serum or plasma, for early and convalescent-phase dengue diagnosis.
• Dengue NS1 Antigen Rapid Test Q-Line Rapid kit for qualitative detection of NS1 antigen of dengue virus in plasma or serum during the acute phase of infection.
• Malaria P.f-PAN Rapid Test Q-Line Rapid test for detection of Plasmodium falciparum antigen and other malaria species (P. vivax, P. malariae, P. ovale, P. knowlesi) in whole blood.
• Malaria P.f / P.v Detection Rapid Test Q-Line Rapid test for detection and differentiation of Plasmodium falciparum and Plasmodium vivax malaria parasites in whole blood.
• Syphilis Antibodies Rapid Test Q-Line Rapid test for detection of Treponema pallidum antibodies causing syphilis infection in whole blood, serum, or plasma, for antenatal and STI clinic screening.
• β-hCG Pregnancy Rapid Test Q-Line Rapid test for qualitative detection of human chorionic gonadotropin (hCG) in urine for early pregnancy detection in clinics and point-of-care settings.
• Coronavirus (COVID-19) IgG Antibody Rapid Test Q-Line Rapid test for detection of SARS-CoV-2 IgG antibodies for sero-surveillance and mass screening purposes.
• Q-Xtra Plus 32W Molecular Extraction System Molecular diagnostics extraction system for RNA/DNA extraction supporting molecular testing workflows in clinical and reference laboratories.
• CDMO / Contract Manufacturing Services for IVD Products Contract Development and Manufacturing Operations (CDMO) service for international diagnostic brands covering instruments, reagents, and rapid test kits under Q-Line Biotech's ISO 13485:2016 quality system, targeted at overseas partners expanding into the IVD market.

Quantifiable outcome

• 190% year-on-year PAT growth in FY26 to ₹5,572 lakh
• +5 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Six partnerships are on record, tiered strategic, core and minor.

• Centre for Cellular and Molecular Platforms (C-CAMP)strategicStrategic or Co-development Partner · 23 April 2024Q-Line Biotech participated in CCAMP Indigenisation of Diagnostics (InDx) program workshop organized in collaboration with WHO India and supported by Gates Foundation India, focusing on global landscape for IVD development and manufacturing with regulatory requirements.
• World Health Organization (WHO) IndiastrategicStrategic or Co-development Partner · 23 April 2024WHO India collaboration through C-CAMP InDx program for workshops on IVD development, manufacturing, and WHO pre-qualification requirements.
• Bill & Melinda Gates Foundation IndiastrategicStrategic or Co-development Partner · 23 April 2024Gates Foundation India supported the CCAMP Indigenisation of Diagnostics program, providing workshop support for cohort companies on IVD regulatory requirements.
• Boule (Sweden)coreTechnology or IntegrationQ-Line Biotech is the authorized representative and distributor for Boule Medonic M32 and Medonic M51 hematology analyzers from Sweden.
• Confederation of Indian Industry (CII)minorGTM or Marketing PartnerActive participation in CII conferences and healthcare events for industry networking and brand visibility.
• International Distributors (65+ countries)coreChannel Partner/ Reseller/ DistributorQ-Line Biotech exports to partners in over 65 countries worldwide through established distribution relationships.

Scale indicators10 records

Recent moves8 records

Expansion highlights6 records

Broad incumbents

• Siemens Healthineers: Global IVD and imaging major. Direct competitor in clinical chemistry and hematology analyzers, especially in Indian tertiary-care hospitals and reference labs.
• Roche Diagnostics: Global IVD market leader with the broadest test menu and deepest installed base in high-volume Indian hospital labs. Sets the benchmark for technology, scale, and pricing Q-Line must compete against.
• Abbott Diagnostics: Global IVD major with strong immunoassay, clinical chemistry, and point-of-care offerings. Competes with Q-Line across Indian hospital segments and shapes procurement standards.

Direct peers

• Transasia Bio-Medicals: India's largest IVD company with a comparable portfolio spanning clinical chemistry, hematology, immunology, and rapid diagnostics. Direct competitor for reagent and analyzer share across Indian hospital and laboratory customers.
• Trivitron Healthcare: Indian medical technology company with a substantial IVD and imaging diagnostics portfolio. Comparable business model combining indigenous manufacturing with international distribution across emerging markets.
• Erba Mannheim: Global IVD manufacturer with strong emerging-market presence through Erba Transasia. Directly competes with Q-Line in clinical chemistry, hematology, and immunoassay reagents and analyzers.
• Agappe Diagnostics: Indian IVD manufacturer with overlapping reagent and analyzer product lines targeting hospital and laboratory customers. Comparable in scale, distribution approach, and Make-in-India positioning.
• Tulip Diagnostics (Perkin Elmer): Indian IVD manufacturer with a broad diagnostics portfolio including rapid tests, ELISA, and clinical chemistry. Direct competitor for reagent and kit sales to Indian diagnostics labs and blood banks.

Emerging players

• Molbio Diagnostics: Indian point-of-care molecular diagnostics company with TrueNAT platform. Adjacent competitor for rapid infectious disease testing, particularly in resource-limited settings.
• Mylab Discovery Solutions: Indian molecular diagnostics and rapid test company. Comparable as a homegrown IVD player benefiting from Make in India tailwinds, though more focused on molecular and infectious disease testing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/qlinebiotech
• YouTubeyoutube.com/@Q-LineBiotech
• Facebookfacebook.com/qlinebiotech
• Instagraminstagram.com/qlinebiotech
• LinkedInlinkedin.com/company/poct-services-pvt-ltd

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Q-Line Biotech